Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 387628Generated: October 30, 2026

Diisopropylethylamine → N-[(1S,2R)-1-benzyl-2-hydroxy-3-{[3-(trifluoromethyl)benzyl]amino}propyl]-1-oxo-2-(1-propylbutyl)-1,2,3,4-tetrahydroisoquinoline-5-carboxamide

https://huagongshe.com/reaction/387628

Reaction equation

Participants

RoleNameHCIDCharge
ReactantDiisopropylethylamineHCID 81531—
Reactant1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 2723939—
Reactant(2R,3S)-3-amino-4-phenyl-1-{[3-(trifluoromethyl)benzyl]amino}butan-2-ol hydrochlorideHCID 57514512—
ReactantHCID 68470583HCID 68470583—
ReactantHCID 178418300HCID 178418300—
SolventWaterHCID 962—
SolventDichloromethaneHCID 6344—
ProductN-[(1S,2R)-1-benzyl-2-hydroxy-3-{[3-(trifluoromethyl)benzyl]amino}propyl]-1-oxo-2-(1-propylbutyl)-1,2,3,4-tetrahydroisoquinoline-5-carboxamideHCID 25206291110.4%

Reaction Steps

43 mg of 1-oxo-2-(1-propylbutyl)-1,2,3,4-tetrahydroisoquinoline-5-carboxylic acid are dissolved in 2.5 cm3 of dichloromethane under an inert atmosphere at a temperature close to 20° C. 62 mg of (2R,3S)-3-amino-4-phenyl-1-{[3-(trifluoromethyl)benzyl]amino}butan-2-ol hydrochloride (2:1), 3 mg of hydroxybenzotriazole and 34 mg of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride are added to the solution. 0.124 cm3 of N,N-diisopropylethylamine is poured into the reaction medium. This medium is kept stirring for 20 h at a temperature close to 20° C. 10 cm3 of dichloromethane are added to the reaction mixture, then 10 cm3 of water. After decantation, the organic phase is washed with 5 cm3 of a saturated aqueous solution of sodium chloride, dried over magnesium sulfate and concentrated using a rotary evaporator under reduced pressure (5 kPa). The 100 mg of colorless oil obtained are purified by flash chromatography over silica (column: 7 g; particle size: 20-40 μm spherical; flow rate: 20 cm3/min; eluent: 100% ethyl acetate). After concentrating the fractions under reduced pressure, 40 mg of N-[(1S,2R)-1-benzyl-2-hydroxy-3-{[3-(trifluoromethyl)benzyl]amino}propyl]-1-oxo-2-(1-propylbutyl)-1,2,3,4-tetrahydroisoquinoline-5-carboxamide are obtained in the form of a colorless oil.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08372864B2
Source datasetuspto-grants-2013_02
ORD IDord-bfafa699f61a43cd9e8521395a2b6d9b
Source noteuspto-grants-2013_02